Netherlands Diabetes Devices Market Report 2022 to 2030

Netherlands Diabetes Devices Market Analysis

$ 3999

The Netherlands Diabetes Devices Market is expected to witness growth from $59 Mn in 2022 to $107 Mn in 2030 with a CAGR of 7.70% for the forecasted year 2022-2030. There has been a consistent rise in the number of diabetes diagnoses in the Netherlands. Manufacturers of diabetes devices now have a great chance to meet the rising demand for diabetes management solutions. The market is segmented by type and by the end user. Some key players in this market include Hy2Care B.V, InnoSer, Johnson & Johnson, Philipps Healthcare, Medtronic, DSM N.V, Roche and Dexcom.

ID: IN10NLMD007 CATEGORY: Medical Devices GEOGRAPHY: Netherlands AUTHOR: Jigyasu Bhandari

Buy Now

Netherlands Diabetes Devices Healthcare Market Executive Analysis

The Netherlands Diabetes Devices Market is at around $59 Mn in 2022 and is projected to reach $107 Mn in 2030, exhibiting a CAGR of 7.70% during the forecast period. The Netherlands allocated 10% of its GDP to health services in 2020 and 2021. In 2021 and 2020, respectively, the Netherlands spent $87.14 Bn and $83.16 Bn on health services. For both years, this amounted to roughly 10% of the GDP. Medical or paramedical treatment cost the Netherlands $54.18 Bn in 2020 or 6.5 per cent of GDP. Compared to other European nations, this is a comparatively small sum. According to this measure of health spending, the Netherlands comes in last place out of 31 European nations.

In the Netherlands, diabetes affected 1.1 million people in 2021 (6.4% of the adult population). Type 2 diabetes is the most common form of illness in the Netherlands, accounting for 90% of cases. The prevalence of diabetes is increasing in the Netherlands, where 58,000 new instances are found each year. Age groups with higher prevalence rates for diabetes include those between the ages of 70 and 79, where rates vary from 3.3% to 17.9%. One of the main sources of morbidity and death in the Netherlands is diabetes. In 2019, diabetes was a contributing factor in roughly 12,000 deaths nationwide. The use of diabetes devices can aid diabetics in better controlling their blood sugar levels and lowering their risk of developing complications like kidney disease, blindness, and amputations. Diabetes sufferers can check their blood glucose levels at home using portable blood glucose metres. They deliver precise and speedy findings, enabling diabetics to make well-informed choices about their diet, exercise regimen, and medication. Diabetes devices can make managing the condition more flexible and convenient and less disruptive to daily living. Insulin is administered to the body through a tiny tube that is inserted under the skin by insulin pumps, which are portable devices. In comparison to conventional insulin injections, they offer a more adaptable and precise method of insulin delivery and can aid those who have diabetes in maintaining better blood sugar management.

Netherlands Diabetes Devices Market Analysis

Market Dynamics

Market Growth Drivers

In the Netherlands, patients and healthcare professionals are becoming more and more conscious of the value of efficient diabetes management. This has increased demand for diabetes devices that can assist people in better controlling their condition. In the future years, it is anticipated that both the prevalence of diabetes and the ageing population in the Netherlands will rise. Simpler and more user-friendly devices are likely to be in higher demand, which will benefit manufacturers who can meet the special requirements of elderly diabetic patients. There has been a consistent rise in the number of diabetes diagnoses in the Netherlands. Manufacturers of diabetes devices now have a great chance to meet the rising demand for diabetes management solutions.

Market Restraints

The Netherlands diabetes devices market is extremely competitive, and a number of well-known companies are already selling a broad variety of items. It might be challenging for new competitors to enter the market and capture a sizable market portion. Diabetes control techniques that are more conventional, like insulin injections and blood glucose monitoring strips, may be preferred by some patients. Manufacturers who are unable to provide products that satisfy patient tastes might have trouble expanding their market share.

Competitive Landscape

Key Players

Hy2Care B.V. (NL)
InnoSer (NL)
DSM N.V. (NL)
Johnson & Johnson
DarioHealth
Medtronic
Philipps Healthcare
Dexcom

Healthcare Policies and Regulatory Landscape

In the Netherlands, the Medical Devices Act governs the efficacy and safety of diabetes devices. Manufacturers are required by the law to acquire a CE mark, which verifies that the product complies with EU safety and performance standards. Greater standards for the security and effectiveness of diabetes devices are laid out in the EU Medical Device Regulation (MDR). Manufacturers must now provide more thorough clinical evidence and carry out post-market surveillance in accordance with a regulation that went into force in May 2021. In the Netherlands, diabetes devices must also adhere to international standards like ISO 13485, which lays out specifications for the quality management systems of diabetes device makers, and ISO 15197, which outlines requirements for blood glucose monitoring systems.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Diabetes Devices Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents

Blood glucose monitoring systems
Self-monitoring blood glucose monitoring systems
Continuous glucose monitoring systems
Test strips/Test papers
Lancets/Lancing Devices
Insulin delivery Devices
Insulin pumps
Insulin pens
Insulin syringes and needles
Diabetes management mobile applications

By End User (Revenue, USD Billion):

The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.

Hospitals & Specialty Clinics
Self & Home Care

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.